ACTRN12609000232235招募中不适用
Randomised, double blind, placebo controlled, cross over study to investigate the effect of dietary supplementation with coenzyme Q10 on endothelial function in males with the metabolic syndrome who are concurrently on statin treatment.
ipid and Diabetes Research Group0 个研究点目标入组 30 人开始时间: 2009年5月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 35 Years 至 65 Years（—）
- 性别
- Male
入选标准
- •Waist circumference >= 94cm
- •Triglycerides >=1.7 mmol/L or specific therapy for tirglycerides
- •Systolic blood presure >=130 mmHg or Diastolic blood pressure >=85 mmHg or treatment for hypertension
- •Statin naive or treatment with <=40mg/day simvastatin or equivalent
排除标准
- •Pre-treatment Low-density Lipoprotein (LDL)-cholesterol <1.5mmol/L or >6.5 mmol/L
- •Pre-treatment triglycerides >5 mmol/L
- •History of cardiovascular event or intervention within the 6 months prior to screening
- •Type 1 diabetes mellitus
- •Type 2 diabetes mellitus requiring oral anti-diabetic agents or insulin
- •Current smoker
- •Treatment with fibrates or other lipid modifying agents other than statin therapy
研究者
相似试验
进行中（未招募）
不适用
Clinical study with randomly into groups divided patients (investigational or ineffective control medication), where neither the doctor nor the patient's know the assignment, to determine the effect of the investigational product (Empagliflozin) on the circulation in the smallest vessels of the body.Type 2 diabetes mellitusMedDRA version: 17.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 100000004861EUCTR2014-003053-34-DEIPPMed – Institut für Pharmakologie und Präventive Medizin GmbH
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy.Duchenne Muscular Dystrophy (DMD)MedDRA version: 19.1Level: PTClassification code 10013801Term: Duchenne muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-000401-36-ITITALFARMACO S.p.A.192
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy.EUCTR2016-000401-36-GBITALFARMACO S.p.A.169
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy.EUCTR2016-000401-36-ESITALFARMACO S.p.A.192
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy.EUCTR2016-000401-36-DEITALFARMACO S.p.A.169